Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

(2021) Filippo G. Dall'Olio et al.   Clinical Lung Cancer

Epithelial–Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma

(2020) HIROE TADA et al.   ANTICANCER RESEARCH

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer

(2019) Yariswamy Manjunath et al.   Cancers

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment

(2019) Simon Heeke et al.   Cells

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer

(2019) Ying Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

(2019) de Miguel-Pérez et al.   Cancers

Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion

(2019) Yuanyuan Jiang et al.   CANCER LETTERS

Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

(2018) Galatea Kallergi et al.   Therapeutic Advances in Medical Oncology

Epithelial‑mesenchymal transition phenotype of circulating tumor cells is associated with distant metastasis in patients with NSCLC

(2018) Xiaochen Zhang et al.   Molecular Medicine Reports

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

(2017) Emmanuel S. Antonarakis et al.   JOURNAL OF CLINICAL ONCOLOGY

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

(2017) Tsukasa Shibue et al.   Nature Reviews Clinical Oncology

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer

(2017) Ippokratis Messaritakis et al.   PLoS One

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

(2017) Issam Chebouti et al.   Oncotarget

EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression

(2017) Arun Satelli et al.   Oncotarget

Association of epithelial-to-mesenchymal transition circulating tumor cells in non-small cell lung cancer (NSCLC) molecular subgroups

(2017) Ippokratis Messaritakis et al.   Journal of Thoracic Disease

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

(2016) C. R. Lindsay et al.   BMC CANCER

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)

(2016) Galatea Kallergi et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung

(2016) Sehui Kim et al.   HUMAN PATHOLOGY

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

(2016) Chiara Nicolazzo et al.   Scientific Reports

Frequent expression of PD-L1 on circulating breast cancer cells

(2015) Martine Mazel et al.   Molecular Oncology

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

(2015) Emmanuel S. Antonarakis et al.   JAMA Oncology

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

(2015) Annkathrin Hanssen et al.   Frontiers in Oncology

Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression

(2014) A. Satelli et al.   CLINICAL CANCER RESEARCH

Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer

(2013) Alberto Fusi et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells

(2013) Monica Charpentier et al.   Cancers

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

(2012) V. Georgoulias et al.   ANNALS OF ONCOLOGY

Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

(2011) V. Hofman et al.   CYTOPATHOLOGY

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

(2011) Matthew G. Krebs et al.   Journal of Thoracic Oncology

Epithelial-to-Mesenchymal Transition Promotes Tubulin Detyrosination and Microtentacles that Enhance Endothelial Engagement

(2010) R. A. Whipple et al.   CANCER RESEARCH

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

(2010) Véronique Hofman et al.   INTERNATIONAL JOURNAL OF CANCER

The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

(2010) Danny R. Youlden et al.   Journal of Thoracic Oncology

Vimentin Filaments Support Extension of Tubulin-Based Microtentacles in Detached Breast Tumor Cells

(2008) R. A. Whipple et al.   CANCER RESEARCH